CurveBeam AI Limited is a medical device company specializing in the research, design, and manufacturing of advanced cone beam computed tomography (CBCT) imaging systems. Its primary focus is on providing point-of-care, weight-bearing medical imaging solutions tailored for orthopedic and bone health applications, including fragility fracture prevention. The company’s product suite includes innovative devices such as HiRise for bilateral weight-bearing CT imaging, LineUP for orthopedic imaging of the knees and lower extremities, and pedCAT systems for imaging the foot and ankle, alongside InReach for extremity CT scans. Complementing its hardware, CurveBeam AI offers proprietary visualization and measurement software, including tools like CurveBeam AI Autometrics, Axiometrics, and TALAS, which leverage artificial intelligence and deep learning to enhance diagnostic precision and automate analysis tasks. With a global operational footprint covering Europe, North America, and Australia, CurveBeam AI Limited plays a significant role in transforming orthopedic imaging by making high-quality, 3D diagnostic tools more accessible in clinical settings. The company operates within the healthcare sector and is recognized for its integration of AI technologies to increase diagnostic efficiency and support better patient outcomes.